Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2024-03-15 | 2024-04-19 | 222464 |
APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2020-06-24 | 2020-08-17 | 118778 |
APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2023-03-16 | 2023-03-30 | 187235 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2023-02-09 | 2023-02-23 | 184109 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2021-05-07 | 2021-06-14 | 138978 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-04 | 2021-08-13 | 140439 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-07-16 | 2021-08-16 | 142690 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-08-27 | 2021-09-14 | 144669 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-11-12 | 2021-11-29 | 149170 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2022-01-21 | 2022-02-28 | 153288 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-08 | 155324 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156555 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2022-03-25 | 2022-04-29 | 157332 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2017-10-23 | 2017-11-29 | 26646 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2017-11-21 | 2018-01-08 | 29949 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2018-01-17 | 2018-05-15 | 36347 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2018-02-01 | 2018-05-15 | 37983 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2017-07-11 | 2017-12-07 | 15409 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2017-08-24 | 2017-10-11 | 20245 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2019-03-05 | 2019-04-26 | 77896 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
APO FUROSEMIDE TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
APO FUROSEMIDE TAB 40MG | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
APO FUROSEMIDE TAB 80MG | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
APO HYDRO TAB 100MG | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO HYDRO TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
APO IBUPROFEN TAB 300MG | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
APO IBUPROFEN TAB 300MG | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
APO IBUPROFEN TAB 400MG | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
APO IBUPROFEN TAB 400MG | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
APO METOPROLOL (TYPE L) TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
APO METOPROLOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO NAPROXEN TAB 250MG | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
APO OXAZEPAM TAB 10MG | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
APO OXAZEPAM TAB 15MG | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO OXAZEPAM TAB 30MG | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |